Krane Funds Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $416K | Buy |
2,243
+584
| +35% | +$108K | 0.02% | 80 |
|
|
2025
Q1 | $348K | Sell |
1,659
-338
| -17% | -$70.8K | 0.01% | 82 |
|
|
2024
Q4 | $355K | Sell |
1,997
-185
| -8% | -$32.9K | 0.01% | 72 |
|
|
2024
Q3 | $431K | Buy |
2,182
+65
| +3% | +$12.8K | 0.02% | 58 |
|
|
2024
Q2 | $363K | Sell |
2,117
-148
| -7% | -$25.4K | 0.02% | 73 |
|
|
2024
Q1 | $407K | Sell |
2,265
-694
| -23% | -$125K | 0.02% | 80 |
|
|
2023
Q4 | $459K | Buy |
2,959
+1,142
| +63% | +$177K | 0.02% | 74 |
|
|
2023
Q3 | $271K | Sell |
1,817
-3,161
| -63% | -$471K | 0.01% | 97 |
|
|
2023
Q2 | $671K | Buy |
4,978
+1,469
| +42% | +$198K | 0.04% | 33 |
|
|
2023
Q1 | $566K | Buy |
+3,509
| New | +$566K | 0.03% | 55 |
|
|
2022
Q3 | – | Sell |
-1,866
| Closed | -$286K | – | 118 |
|
|
2022
Q2 | $286K | Buy |
+1,866
| New | +$286K | 0.01% | 172 |
|